Avacta Group PLC
LSE:AVCT
Avacta Group PLC
Accounts Payable
Avacta Group PLC
Accounts Payable Peer Comparison
Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors
Company | Accounts Payable | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Avacta Group PLC
LSE:AVCT
|
Accounts Payable
£10.8m
|
CAGR 3-Years
54%
|
CAGR 5-Years
40%
|
CAGR 10-Years
24%
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Accounts Payable
$11.8m
|
CAGR 3-Years
128%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Accounts Payable
$103k
|
CAGR 3-Years
-64%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Accounts Payable
$7.1m
|
CAGR 3-Years
92%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Accounts Payable
£17.8m
|
CAGR 3-Years
45%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
|
Genus PLC
LSE:GNS
|
Accounts Payable
£34.9m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-4%
|
See Also
What is Avacta Group PLC's Accounts Payable?
Accounts Payable
10.8m
GBP
Based on the financial report for Jun 30, 2023, Avacta Group PLC's Accounts Payable amounts to 10.8m GBP.
What is Avacta Group PLC's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
24%
Over the last year, the Accounts Payable growth was 132%. The average annual Accounts Payable growth rates for Avacta Group PLC have been 54% over the past three years , 40% over the past five years , and 24% over the past ten years .